(PRWEB) September 28, 2009
The Frost & Sullivan Award for Company of the Year is presented each year to the company that has demonstrated unparalleled excellence within its industry. Industry analysts compare market participants and measure performance through in-depth interviews, analysis, and extensive secondary research in order to identify best practices in the industry.
"Veeda's significant market share in the highly competitive Phase 1 and BA/BE market in India and proven expertise in taking advantage of market changes by capturing and solidifying market presence is what caught Frost & Sullivan's attention." Mr. Apurva Shah, Co-Group Managing Director and Co-Founder, Veeda.
In order to select the Award recipient, Frost & Sullivan's analysts quantify several market factors for each market participant according to predetermined criteria, paying close attention to their combined operations efforts. This process includes interviews with all the market participants, customers, and suppliers, along with extensive secondary and technology research. The companies' efforts are then analyzed based on the number of new customers, new segments, and commitment to business expansion coupled with market growth. Industry participants are then ranked based on the predetermined measurement criteria. The Award recipient is the company that received the number one industry rank.
"Combining strategic acquisitions with focused areas of specialty, unique offerings and consistent growth are the cumulative factors for which Frost & Sullivan have considered Veeda the worthy recipient of the award", Mr. Binoy Gardi, Co-Group Managing Director and Co-Founder, Veeda.
About Veeda Clinical Research:
Veeda Clinical Research is a leading CRO specializing in the early clinical development of drugs. With state of the art clinical pharmacology units in the UK and India, fully complaint GLP Laboratories and an established Biometrics team in Belgium and India, Veeda is able to offer clients a full range of phase I and IIa services. In addition, Veeda maintains an extensive database of volunteers from which to accrue appropriate subjects in a timely fashion.
About Veeda Oncology:
Veeda Oncology is a global Oncology CRO with operations in India, Europe and the US. The company is a full service Oncology CRO for Phase I through Phase IV studies with the unique capability of providing rapid and strong global patient accrual with an effective cost structure.
# # #